EGFR-TKIs inhibit TK self-phosphorylation by competing with adenosine triphosphate for the binding sites of the TK domain, thereby blocking the transmission of downstream signaling and inhibiting tumor cell proliferation (8). This evidence concerns the gene TKT and neoplasm.